These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 19919989)

  • 1. Adaptive and maladptive effects of SMAD3 signaling in the adult heart after hemodynamic pressure overloading.
    Divakaran V; Adrogue J; Ishiyama M; Entman ML; Haudek S; Sivasubramanian N; Mann DL
    Circ Heart Fail; 2009 Nov; 2(6):633-42. PubMed ID: 19919989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smad3 Signaling Promotes Fibrosis While Preserving Cardiac and Aortic Geometry in Obese Diabetic Mice.
    Biernacka A; Cavalera M; Wang J; Russo I; Shinde A; Kong P; Gonzalez-Quesada C; Rai V; Dobaczewski M; Lee DW; Wang XF; Frangogiannis NG
    Circ Heart Fail; 2015 Jul; 8(4):788-98. PubMed ID: 25985794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-acetyl-seryl-aspartyl-lysyl-proline prevents cardiac remodeling and dysfunction induced by galectin-3, a mammalian adhesion/growth-regulatory lectin.
    Liu YH; D'Ambrosio M; Liao TD; Peng H; Rhaleb NE; Sharma U; André S; Gabius HJ; Carretero OA
    Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H404-12. PubMed ID: 19098114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of miR-21 is involved in direct actions of ursolic acid on the heart: implications for cardiac fibrosis and hypertrophy.
    Dong X; Liu S; Zhang L; Yu S; Huo L; Qile M; Liu L; Yang B; Yu J
    Cardiovasc Ther; 2015 Aug; 33(4):161-7. PubMed ID: 25903305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Smad3-miR-29b/miR-29c axis mediates the protective effect of macrophage migration inhibitory factor against cardiac fibrosis.
    Liang JN; Zou X; Fang XH; Xu JD; Xiao Z; Zhu JN; Li H; Yang J; Zeng N; Yuan SJ; Pan R; Fu YH; Zhang M; Luo JF; Wang S; Shan ZX
    Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2441-2450. PubMed ID: 31175931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-195 inhibits myocardial fibrosis in hypertensive rats by regulating TGFβ1-Smad3 signaling pathway.
    Xu Q; Lin XX; Liu P; Zhang W; Tang K; Zhai YS; Liu LJ; Mei WY
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):8087-8094. PubMed ID: 31599435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The microRNA-15 family inhibits the TGFβ-pathway in the heart.
    Tijsen AJ; van der Made I; van den Hoogenhof MM; Wijnen WJ; van Deel ED; de Groot NE; Alekseev S; Fluiter K; Schroen B; Goumans MJ; van der Velden J; Duncker DJ; Pinto YM; Creemers EE
    Cardiovasc Res; 2014 Oct; 104(1):61-71. PubMed ID: 25103110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Essential role of Smad3 in infarct healing and in the pathogenesis of cardiac remodeling.
    Bujak M; Ren G; Kweon HJ; Dobaczewski M; Reddy A; Taffet G; Wang XF; Frangogiannis NG
    Circulation; 2007 Nov; 116(19):2127-38. PubMed ID: 17967775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-beta receptor antagonism attenuates myocardial fibrosis in mice with cardiac-restricted overexpression of tumor necrosis factor.
    Sakata Y; Chancey AL; Divakaran VG; Sekiguchi K; Sivasubramanian N; Mann DL
    Basic Res Cardiol; 2008 Jan; 103(1):60-8. PubMed ID: 18034274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone Morphogenetic Protein 9 Reduces Cardiac Fibrosis and Improves Cardiac Function in Heart Failure.
    Morine KJ; Qiao X; York S; Natov PS; Paruchuri V; Zhang Y; Aronovitz MJ; Karas RH; Kapur NK
    Circulation; 2018 Jul; 138(5):513-526. PubMed ID: 29487140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gallic acid prevents isoproterenol-induced cardiac hypertrophy and fibrosis through regulation of JNK2 signaling and Smad3 binding activity.
    Ryu Y; Jin L; Kee HJ; Piao ZH; Cho JY; Kim GR; Choi SY; Lin MQ; Jeong MH
    Sci Rep; 2016 Oct; 6():34790. PubMed ID: 27703224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. microRNA-29b Mediates the Antifibrotic Effect of Tanshinone IIA in Postinfarct Cardiac Remodeling.
    Yang F; Li P; Li H; Shi Q; Li S; Zhao L
    J Cardiovasc Pharmacol; 2015 May; 65(5):456-64. PubMed ID: 25636075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-101a suppresses fibrotic programming in isolated cardiac fibroblasts and in vivo fibrosis following trans-aortic constriction.
    Zhou Y; Shiok TC; Richards AM; Wang P
    J Mol Cell Cardiol; 2018 Aug; 121():266-276. PubMed ID: 30053527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective Effects of Activated Myofibroblasts in the Pressure-Overloaded Myocardium Are Mediated Through Smad-Dependent Activation of a Matrix-Preserving Program.
    Russo I; Cavalera M; Huang S; Su Y; Hanna A; Chen B; Shinde AV; Conway SJ; Graff J; Frangogiannis NG
    Circ Res; 2019 Apr; 124(8):1214-1227. PubMed ID: 30686120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth/differentiation factor 1 alleviates pressure overload-induced cardiac hypertrophy and dysfunction.
    Zhang Y; Zhang XF; Gao L; Liu Y; Jiang DS; Chen K; Yang Q; Fan GC; Zhang XD; Huang C
    Biochim Biophys Acta; 2014 Feb; 1842(2):232-44. PubMed ID: 24275554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac lineage protein-1 (CLP-1) regulates cardiac remodeling via transcriptional modulation of diverse hypertrophic and fibrotic responses and angiotensin II-transforming growth factor β (TGF-β1) signaling axis.
    Mascareno E; Galatioto J; Rozenberg I; Salciccioli L; Kamran H; Lazar JM; Liu F; Pedrazzini T; Siddiqui MA
    J Biol Chem; 2012 Apr; 287(16):13084-93. PubMed ID: 22308025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin attenuates cardiac fibrosis by inhibiting the TGFbeta1-Smad3 signalling pathway.
    Xiao H; Ma X; Feng W; Fu Y; Lu Z; Xu M; Shen Q; Zhu Y; Zhang Y
    Cardiovasc Res; 2010 Aug; 87(3):504-13. PubMed ID: 20200042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage migration inhibitory factor antagonizes pressure overload-induced cardiac hypertrophy.
    Koga K; Kenessey A; Ojamaa K
    Am J Physiol Heart Circ Physiol; 2013 Jan; 304(2):H282-93. PubMed ID: 23144312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial inhibition of activin receptor-like kinase 4 attenuates pressure overload-induced cardiac fibrosis and improves cardiac function.
    Li CY; Chen YH; Wang Q; Hou JW; Wang H; Wang YP; Li YG
    J Hypertens; 2016 Sep; 34(9):1766-77. PubMed ID: 27379535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADAMTS16 activates latent TGF-β, accentuating fibrosis and dysfunction of the pressure-overloaded heart.
    Yao Y; Hu C; Song Q; Li Y; Da X; Yu Y; Li H; Clark IM; Chen Q; Wang QK
    Cardiovasc Res; 2020 Apr; 116(5):956-969. PubMed ID: 31297506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.